Ratos sells Nordic Cinema Group - exit gain approximately

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Ratos sells Nordic Cinema Group - exit gain approximately SEK 900m

This information is disclosed in accordance with the Securities Markets Act, the Financial Instruments Trading Act or demands made in the exchange rules.

Ratos has signed an agreement on the sale of the subsidiary Nordic Cinema Group, the leading cinema operator in the Nordic and Baltic regions, to Bridgepoint. The enterprise value amounts to approximately SEK 4,700m and Ratos will receive approximately SEK 1,700m for its shareholding. The sale generates an exit gain of approximately SEK 900m and an average annual return (IRR) of approximately 42%. The sale is subject to approval from the relevant authorities.

In 2011, Ratos acquired Finnkino, the leading cinema operator in Finland and the Baltic countries. Nordic Cinema Group (NCG) was formed two years later through a merger of Bonnier-owned SF Bio and Ratos-owned Finnkino and is today the leading cinema operator in the Nordic and Baltic regions with 66 wholly owned cinemas with 444 screens in approximately 50 major towns. NCG is also co-owner of an additional 48 cinemas. NCG operates with four strong brands in six markets: SF Bio in Sweden, Finnkino in Finland, SF Kino in Norway and Forum Cinemas in Estonia, Latvia and Lithuania. In 2014 Nordic Cinema Group's sales totalled SEK 2,612m and EBITA amounted to SEK 366m.

Susanna Campbell, CEO of Ratos, comments: "Together with Bonnier we have created a strong Nordic cinema operator with a leading market position and good profitability. This provides good opportunities for the company in the future and enables continued investment in modern cinemas and development of the customer offering. The company is well positioned to continue to deliver exciting film experiences in the future. A strong focus on value creation throughout the entire holding period has generated a good return and led to a successful transaction for Ratos."

In April 2011, Ratos acquired Finnkino and in May 2013 a merger took place between SF Bio and Finnkino which formed NCG where Ratos received a holding of 58% in the new group. Ratos's net invested capital amounts to approximately SEK 360m. Co-owners are Bonnier (40%) and the company's board and management.

Ratos has signed an agreement with Bridgepoint to sell its entire holding for a price for Ratos's shareholding of approximately SEK 1,700m. The sale generates an estimated exit gain of approximately SEK 900m and an average annual return (IRR) of approximately 42%.

The sale is subject to approval from the relevant authorities and is expected to be completed in the summer.

For further information, please contact: Susanna Campbell, CEO, +46 8 700 17 00 Elin Ljung, Head of Corporate Communications, +46 8 700 17 20

Financial calendar from Ratos:  
Interim report January-March 2015 7 May 2015
Interim report January-June 2015 14 August 2015
Interim report January-September 2015 6 November 2015

Ratos is a private equity conglomerate. The company's mission is to maximise shareholder value over time through the professional, active and responsible exercise of its ownership role in primarily unlisted medium sized Nordic companies. Ratos's holdings include AH Industries, Aibel, Arcus-Gruppen, Biolin Scientific, Bisnode, DIAB, Euromaint, GS-Hydro, Hafa Bathroom Group, HENT, HL Display, Inwido, Jøtul, KVD, Ledil, Mobile Climate Control, Nebula and Nordic Cinema Group. Ratos is listed on Nasdaq Stockholm and market capitalisation amounts to approximately SEK 21 billion.

Press release (PDF) http://hugin.info/1180/R/1915676/684781.pdf

HUG#1915676

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

BiomX Advances Phage-Based Therapy for Diabetic Foot Infections

Updated Category News Views 128

BiomX's Innovative Approach to Diabetic Foot Infections BiomX Inc. (NYSE: PHGE), a pioneering clinical-stage company specializing in natural and engineered phage therapies, has announced exciting developments regarding its novel treatment for diabetic foot infections (DFI). Following supportive feedback from the U.S. Food and Drug Administration (FDA), BiomX is gearing up...

Continue Reading
Moneta's Remote Brain Therapy Beats In-Person Results

Updated Category News Views 35

Innovation in Brain Health Comes via Telephone, Not Apps Sometimes, it's astonishing to see how a simple idea can disrupt an entire industry. Take Moneta Health, for example. Their approach is giving the whole world a wake-up call, quite literally. They're not flaunting fancy new apps or diving deep into virtual reality. Instead, they're harnessing the power of a simple...

Continue Reading
Nextensa Boosts Liquidity with Successful Sale of Shares

Updated Category News Views 167

Nextensa Strengthens Financial Position with Recent Share Sale Nextensa NV/SA, widely recognized as a mixed property investor and developer, has recently achieved a notable financial milestone. The company announced the successful completion of a strategic share sale involving Wereldhave N.V., which has significantly enhanced its liquidity position and set the stage for...

Continue Reading
Taylor Farms Group Unveils Comprehensive Impact Initiatives

Updated Category News Views 140

Taylor Farms Group Unveils Comprehensive Impact Initiatives Highlights Achievements and Continuous Efforts to Nourish Both People and Planet Taylor Farms has recently published its latest Impact Report, showcasing innovative initiatives related to products, processes, people, and community involvement. As a prominent supplier of ready-to-eat salads and healthy fresh...

Continue Reading
Compass, Inc. to Share Annual Results and Insights Soon

Updated Category News Views 130

Compass, Inc. Plans Upcoming Financial Results Announcement Compass, Inc., also known as Compass International Holdings (NYSE: COMP), a leader in global real estate services, is preparing to announce its financial results for the fourth quarter and full-year 2025. This important update will take place after the market closes on February 26, 2026. Investors and...

Continue Reading